Retina Synthesis

147 Episodes

1. 18 Month Results of the Derby and Oaks Trials for Treatment of Geographic Atrophy

   Published: 8/4/2022
2. A Novel Retinal Sealant

   Published: 7/28/2022
3. New Developments in Imaging and Therapy of Sickle Cell Retinopathy

   Published: 7/21/2022
4. High Dose (8mg) Aflibercept for Treatment of Neovascular AMD

   Published: 7/7/2022
5. New Developments in the Management of Choroidal Melanoma

   Published: 6/30/2022
6. A Stem Cell Implant for the Treatment of Geographic Atrophy

   Published: 6/23/2022
7. DERBY and OAKS Results

   Published: 6/16/2022
8. Artificial Intelligence in the Management of Macular Degeneration

   Published: 6/9/2022
9. An Oral Agent for the Treatment of Diabetic Retinopathy

   Published: 6/2/2022
10. Home OCT Monitoring of Neovascular AMD Treatment

    Published: 5/26/2022
11. Faricimab in Diabetic Macular Edema: 2 Year Results of the RHINE and YOSEMITE studies

    Published: 5/19/2022
12. The Kingfisher Trial of Brolucizumab for DME

    Published: 5/12/2022
13. Subretinal Fluid in Neovascular AMD: Friend or Foe?

    Published: 5/5/2022
14. Optogenetics

    Published: 4/28/2022
15. Inhibition of Plasma Kallikrein in Diabetic Macular Edema

    Published: 4/21/2022
16. Neovascular AMD: Unpacking Surgical Disease Management Options

    Published: 4/14/2022
17. Ocular Therapeutics Sustained Release TKI Trial

    Published: 4/7/2022
18. Gene Therapy of nAMD and Diabetic Retinopathy with Dr. Allen Ho

    Published: 3/31/2022
19. Long Term Results of the Port Delivery System

    Published: 3/24/2022
20. The Altissimo Study using a TKI for nAMD

    Published: 3/17/2022